Comparison of the effects of methadone and heroin on human ether-à-go-go-related gene channels

Cardiovascular Toxicology

Volumn 10, Issue 3, 2010, Pages 161-165

  Zünkler, Bernd J ^a   Wos Maganga, Maria ^a  

^a FEDERAL INSTITUTE FOR DRUGS AND MEDICAL DEVICES   (Germany)

Author keywords

hERG channel; Heroin; Methadone

Indexed keywords

DIAMORPHINE; METHADONE; POTASSIUM CHANNEL HERG;

ARTICLE; CELL STRAIN HEK293; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IC 50; INHIBITION KINETICS; PATCH CLAMP; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN EXPRESSION;

DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; ETHER-A-GO-GO POTASSIUM CHANNELS; HEK293 CELLS; HEROIN; HUMANS; METHADONE; NARCOTICS; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNEL BLOCKERS; TORSADES DE POINTES;

EID: 77956338990     PISSN: 15307905     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12012-010-9074-y     Document Type: Article

References (24)

1. MT Keating MC Sanguinetti 1996 Molecular genetic insights into cardiovascular disease Science 272 681 685 10.1126/science.272.5262.681 1:CAS:528:DyaK28Xislamsb4%3D 8614827
2. JW Warmke B Ganetzky 1994 A family of potassium channel genes related to eag in Drosophila and mammals Proceedings of the National Academy of Sciences of the United States of America 91 3438 3442 10.1073/pnas.91.8.3438 1:CAS:528:DyaK2cXksFWjt74%3D 8159766
3. MC Sanguinetti C Jiang ME Curran MT Keating 1995 A mechanistic link between an inherited and an acquired cardiac arrhythmia Cell 81 299 307 10.1016/0092-8674(95)90340-2 1:CAS:528:DyaK2MXlt1Kis7w%3D 7736582
4. MC Trudeau JW Warmke B Ganetzky GA Robertson 1995 hERG, a human inward rectifier in the voltage-gated potassium channel family Science 269 92 95 10.1126/science.7604285 1:CAS:528:DyaK2MXmsl2ju7k%3D 7604285
5. + channel blockade: Current knowledge and strategies for the early prediction during drug development Medicinal Research Reviews 25 133 166 10.1002/med.20019 1:CAS:528:DC%2BD2MXitlWhs7Y%3D 15389727
6. WS Redfern L Carlsson AS Davis WG Lynch I MacKenzie S Palethorpe PK Siegl I Strang AT Sullivan R Wallis AJ Camm TG Hammond 2003 Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: Evidence for a provisional safety margin in drug development Cardiovascular Research 58 32 45 10.1016/S0008-6363(02)00846-5 1:CAS:528:DC%2BD3sXit12gsb8%3D 12667944
7. International conference on harmonization S7B guideline (CPMP/ICH/423/02; 2005). The nonclinical evaluation of the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals. http://www.emea.europa.eu/pdfs/human/ich/042302en.pdf.
8. + currents Journal of Pharmacology and Experimental Therapeutics 303 688 694 10.1124/jpet.102.038240 1:CAS:528:DC%2BD38XotlCnsrk%3D 12388652
9. CB Eap S Crettol J-S Rougier J Schläpfer L Sintra Grilo J-J Deglon J Besson M Croquette-Krokar P-A Carrupt H Abriel 2007 Stereoselective block of hERG channel by (S)-methadone and QT interval prolongation in CYP2B6 slow metabolizers Clinical Pharmacology and Therapeutics 81 719 728 10.1038/sj.clpt.6100120 1:CAS:528:DC%2BD2sXlsFCqsbc%3D 17329992
10. MJ Krantz J Martin B Stimmel D Mehta MCP Haigney 2009 QTc interval screening in methadone treatment Annals of Internal Medicine 150 387 395 19153406
11. C Lin T Somberg J Molnar J Somberg 2009 The effects of chiral isolates of methadone on the cardiac potassium channel IKr Cardiology 113 59 65 10.1159/000167043 1:CAS:528:DC%2BD1MXktVGkt7c%3D 18984955
12. OP Hamill A Marty E Neher B Sakmann FJ Sigworth 1981 Improved patch-clamp techniques for high-resolution current recordings from cells and cell-free membrane patches Pfluegers Archiv 391 85 100 10.1007/BF00656997 1:STN:280:DyaL38%2FjslWrug%3D%3D 6270629
13. JW de Vos PJ Geerlings W van den Brink JG Ufkes H van Wilgenburg 1995 Pharmacokinetics of methadone and its primary metabolite in 20 opiate addicts European Journal of Clinical Pharmacology 48 361 366 10.1007/BF00194951 8641323
14. MK Romach KM Piafsky JG Abel V Khouw EM Sellers 1981 Methadone binding to orosomucoid (alpha 1-acid glycoprotein): Determinant of free fraction in plasma Clinical Pharmacology and Therapeutics 29 211 217 1:CAS:528:DyaL3MXhtlWqt7s%3D 7193106
15. CE Inturrisi WA Colburn RF Kaiko RW Houde KM Foley 1987 Pharmacokinetics and pharmacodynamics of methadone in patients with chronic pain Clinical Pharmacology and Therapeutics 41 392 401 1:STN:280:DyaL2s7mtVensQ%3D%3D 3829576
16. M Benmebarek C Devaud M Gex-Fabry K Powell Golay C Brogli P Baumann B Gravier CB Eap 2004 Effects of grapefruit juice on the pharmacokinetics of the enantiomers of methadone Clinical Pharmacology and Therapeutics 76 55 63 10.1016/j.clpt.2004.03.007 1:CAS:528:DC%2BD2cXlsVaqtrk%3D 15229464
17. EJ Rook ADR Huitema W van den Brink JM van Ree JH Beijnen 2006 Population pharmacokinetics of heroin and its major metabolites Clinical Pharmacokinetics 45 401 417 10.2165/00003088-200645040-00005 1:CAS:528:DC%2BD28XptlCjtrw%3D 16584286
18. GL Cohn JA Cramer W McBride RC Brown HD Kleber 1974 Heroin and morphine binding with human serum proteins and red blood cells Proceedings of the Society for Experimental Biology and Medicine 147 664 666 1:CAS:528:DyaE2MXhs1CltrY%3D 4445151
19. JS Mitcheson J Chen M Lin C Culberson MC Sanguinetti 2000 A structural basis for drug-induced long QT syndrome Proceedings of the National Academy of Sciences of the United States of America 97 12329 12333 10.1073/pnas.210244497 1:CAS:528:DC%2BD3cXnvVSnsro%3D 11005845
20. MC Sanguinetti JS Mitcheson 2005 Predicting drug-hERG channel interactions that cause acquired long QT syndrome Trends in Pharmacological Sciences 26 119 124 10.1016/j.tips.2005.01.003 1:CAS:528:DC%2BD2MXitVeisLg%3D 15749156
21. BJ Zünkler 2006 Human ether-a-go-go-related (hERG) gene and ATP-sensitive potassium channels as targets for adverse drug effects Pharmacology and Therapeutics 112 12 37 10.1016/j.pharmthera.2006.03.002 16647758
22. JT Milnes O Crociani A Arcangeli JC Hancox HJ Witchel 2003 Blockade of hERG potassium currents by fluvoxamine: Incomplete attenuation by S6 mutations at F656 or Y652 British Journal of Pharmacology 139 887 898 10.1038/sj.bjp. 0705335 1:CAS:528:DC%2BD3sXlvVCjurY%3D 12839862
23. JS Mitcheson 2003 Drug binding to hERG channels: Evidence for a "non-aromatic" binding site for fluvoxamine British Journal of Pharmacology 139 883 884 10.1038/sj.bjp.0705336 1:CAS:528:DC%2BD3sXlvVCjurg%3D 12839860
24. D Stork EN Timin S Berjukow C Huber A Hohaus M Auer S Hering 2007 State dependent dissociation of hERG channel inhibitors British Journal of Pharmacology 151 1368 1376 10.1038/sj.bjp.0707356 1:CAS:528:DC%2BD2sXovFehsLk%3D 17592502